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The emergence and rapid global spread of SARS-CoV-2 mark the third such identification of a novel corona-
virus capable of causing severe, potentially fatal disease in humans in the 21st century. As noted by Andersen
et al. (NatureMedicine), the sequencing of proximal zoonotic ancestors to SARS-CoV-2 has aided in the iden-
tification of alleles that may contribute to the virus’ virulence in humans.Three novel coronaviruses that are
capable of causing severe disease have
emerged in human populations in the
21st century. The 2003 severe acute respi-
ratory coronavirus (SARS-CoV) and the
2012 Middle East respiratory coronavirus
(MERS-CoV) foreshadowed the emer-
gence potential of zoonotic coronavi-
ruses. In December 2019, a strain of
coronavirus that was 22% different from
the 2003 SARS-CoV, later named severe
acute respiratory syndrome strain 2
(SARS-CoV-2), emerged in Wuhan,
China, and the resulting pandemic has
caused over 3.2 million confirmed infec-
tions and over 225,000 deaths in nearly
5 months (as of April 29, 2020). The
advent of high-throughput sequencing
technologies has simplified the tracking
of viral sequence diversity and evolution
in both human and animal populations.
Metagenomic surveillance of bat popula-
tions in areas near population centers in
China has led to the identification of
numerous civet and bat coronavirus
strains closely related to the 2003 SARS-
CoV. Moreover, strains like BatCoV-
RaTG13 and pangolin GD/P2S1 share
96.2% and <90%, respectively, genome
identity with SARS-CoV-2 (Lam et al.,
2020; Zhang et al., 2020; Zhou et al.,
2020) (Figure 1). Recently, Andersen
et al. (2020) outlined the two most notable
genetic features of SARS-CoV-2 that
likely contribute to its virulence in hu-
mans: (1) a receptor-binding domain
(RBD) that is optimized for binding to the
human angiotensin-converting enzyme 2
(hACE2) molecule as the viral receptor
and (2) the presence of a polybasic (furin)
cleavage site at the S1-S2 boundary in the
spike protein. The authors describe how
these features contribute to virulence in
other betacoronaviruses and then sketchtwo possibilities by which they may,
through natural selection processes,
have arisen in the coronavirus currently in-
fecting humans worldwide.
Of the 14 residues of the RBD of 2003
SARS-CoV known to interact with
hACE2 (Li et al., 2005), six residues are
more critical for RBD-hACE2 binding
and are host range determinants for
SARS-CoV-like viruses (Wan et al.,
2020). Interestingly, SARS-CoV and
SARS-CoV-2 differ at 8/14 of these resi-
dues, including 5/6 critical interacting res-
idues, and in vitro and structural studies
indicate that SARS-CoV-2 has affinity for
ACE2 molecules with high homology to
hACE2 (Wan et al., 2020). However, while
computational analyses indicate that this
interaction has high affinity, the RBD
sequence is clearly different from those
shown to be optimal for hACE2 binding,
suggesting that this binding interface is a
product of a natural selection process on
hACE2 or a human-like animal ACE2.
The other distinctive genetic feature
SARS-CoV-2 possesses that potentially
mediates virulence in humans is a polyba-
sic (i.e., furin) cleavage site at the S1-S2
junction in the spike amino acid
sequence. This site allows cleavage by
proteases such as furin and is another
factor that can determine viral infectivity
and host range (Nao et al., 2017). While
such cleavage sites have not been de-
tected in other lineage B betacoronavi-
ruses, they have been identified in
betacoronaviruses in lineages A and C
(in HCoV-HKU1 and MERS-like CoVs,
respectively). Moreover, the O-linked gly-
cans likely associated with the polybasic
sitemay alter immunogenicity in response
to herd immunity within natural animal
hosts, which is likely not necessary in
naive human populations (Bagdonaiteand Wandall, 2018). Thus, the functional
significance of the polybasic cleavage
site awaits characterization.
In light of social media speculation
about possible laboratory manipulation
and deliberate and/or accidental release
of SARS-CoV-2, Andersen et al. theorize
about the virus’ probable origins, empha-
sizing that the available data argue over-
whelmingly against any scientific miscon-
duct or negligence (Andersen et al., 2020).
As has been previously described, the
SARS-CoV-genome contains over 1,200
nucleotide changes as compared with
RaTG13, its closest relative. Moreover,
the RaTG13 S glycoprotein is 97% iden-
tical at the amino acid level to the SARS-
CoV-2 S glycoprotein (Figure 1), and it
encodes an RBD that is not optimized
for hACE2 interaction (Wan et al., 2020).
Anderson cites these genetic and biolog-
ical data as strong evidence against delib-
erate generation, and the arguments are
compelling. It is noteworthy that many
early COVID-19 cases had not visited
the Huanan wet market, suggesting that
either the index cases occurred earlier
and were not identified or that these sites
were not major sites of epidemic expan-
sion. How, then, did the virus emerge?
Anderson et al. citemultiple lines of strong
evidence that argue, instead, in favor of
various mechanisms of natural selection,
either in an animal host before the virus
was transmitted to humans or in humans
after the zoonotic transmission event(s).
These possibilities will be reviewed
below. Nevertheless, speculation about
accidental laboratory escape will likely
persist, given the large collections of bat
virome samples stored in labs in the Wu-
han Institute of Virology, the facility’s
proximity to the early outbreak, and the
operating procedures at the facility
Figure 1. Genome Phylogeny and Spike and Receptor-Binding Domain Identity of Representative Group 2b Betacoronaviruses
The genome, spike, and RBD sequences of selected group 2b betacoronaviruses were aligned and phylogenetically compared. Sequences were aligned using
free end gaps with the Blosum62 cost matrix in Geneious Prime. The phylogenetic tree was constructed from the multiple genome sequence alignment using the
neighbor-joining method based on 100 replicates, also in Geneious Prime. The GenBank accession number follows each sequence name. Spike and RBD amino
acid sequence identities from their respective alignments are represented by color-coded boxes to the right of each tree position, with colors ranging from yellow
(~60% similarity) to purple (~100% similarity), shown in the scale in the lower right. Identities are represented as versus 2003 SARS-CoV spike (listed in figure as
‘‘2003 SARS Spike’’), versus SARS-CoV-2 spike (‘‘SARS-2 Spike’’), versus 2003 SARS-CoV RBD (‘‘2003 SARS RBD’’), and versus SARS-CoV-2 RBD (‘‘SARS-2
RBD’’). The phylograms and alignments were exported from Geneious and then rendered for publication using EvolView (www.evolgenius.info) and Adobe
Illustrator CC 2020.(Zeng et al., 2016). Transparency and
open scientific investigation will be essen-
tial to resolve this issue, noting that
forensic evidence of natural escape is
currently lacking, and other explanations
remain reasonable.
Given the high correlation of many, but
not all, of the early cases of COVID-19 dis-
ease in Wuhan with the Huanan wet mar-
ket, it is possible that an animal reservoir
of the virus was present at that location,
and genome evolution analyses have sug-
gested an earlier time of origin (Zhang
et al., 2020). This scenario would have al-lowed for the establishment of earlier hu-
man-to-human transmission networks in-
dependent of the open market. The
BtCoV-RaTG13 virus is the closest
currently characterized relative to SARS-
CoV-2, and it encodes 7/14 changes in
the S glycoprotein RBD. More distantly
related coronavirus genome sequences
have also been identified in illegally im-
ported Malayan pangolins (Lam et al.,
2020), and while these strains encode 8/
14 changes in the RBD interface residues,
they do retain 6/6 of the most critical
ACE2-interacting RBD residues withSARS-CoV-2 (Lam et al., 2020; Zhang
et al., 2020). The presence of highly
related viral sequences in diverse species
argues strongly for natural selection being
themajor driving force for the optimization
of the SARS-CoV-2 spike RBD among
these related viruses. While a more ho-
mologous zoonotic relative has yet to be
identified that shares the polybasic site
with SARS-CoV-2, the sheer diversity of
coronavirus sequences that have been
identified in bat populations in China and
worldwide indicates that zoonotic reser-
voirs are drastically under-sampled and
under-characterized. Clearly, additional 
studies into the diversity of zoonotic coro-
navirus strains are essential for global 
public health preparedness, for the devel-
opment of countermeasures, and to 
clarify the origins of SARS-CoV-2.
Anderson et al. also argue that it is 
possible that a progenitor coronavirus 
jumped to humans prior to acquiring its 
polybasic site and key hACE2 interaction 
residues, acquiring these features 
through undetected human-to-human 
transmission events prior to the first docu-
mented cases of COVID-19 disease that 
triggered human surveillance systems 
(Wu et al., 2020; Zhou et al., 2020). In sup-
port, antibodies targeting the group 2b 
SARS-like coronaviruses can be detected 
in people living and working near or in bat 
hibernacula in China, suggesting frequent 
exposures in a rural setting. As SARS-
CoV-2 infections are frequently asymp-
tomatic or mild, initial exposures would 
easily have allowed for extended silent 
transmission events in rural settings prior 
to the emergence of a strain that could 
support sustained human-to-human 
transmission, especially when brought 
into an urban setting.
As emphasized by the authors, retroac-
tive mapping of the paths of emergence of 
human pathogens is critical, especially in 
light of the global emergency fomented 
by the current pandemic. The presence 
of abundant sources of coronaviruses in 
zoonotic populations and the continuing 
and advancing encroachment of humans 
into animal habitats argue that emergence 
events will only become more common in 
future years. Indeed, prior to 2003, only 
two human coronaviruses were known: 
HCoV-OC43 and HCoV-229E, which 
cause mild, cold-like disease. After 
2003, heightened surveillance retroac-
tively identified two additional human 
coronaviruses, HCoV-NL63 and HCoV-
HKU1. Nearly 10 years separated the 
documented emergence of SARS-CoV in 
2003 and MERS-CoV in 2012, and just un-
der 8 years have now separated the emer-
gences of MERS-CoV and SARS-CoV-2.These patterns suggest that the global
ecology has shifted and now favors the
continued emergence of zoonotic coro-
naviruses, resulting in micro-outbreaks,
continued low-level epidemics, or global
pandemics.
In summary, Andersen et al. have out-
lined many of the key elements of the
SARS-CoV-2 spike protein that could
be mediating its extraordinary global
expansion and summarize how the virus
may have emerged from zoonotic popu-
lations (Andersen et al., 2020). The au-
thors do not discuss the potential role
for other less defined virulence determi-
nants in the spike protein that alter host
signaling networks and cytokine levels
that may be associated with disease or
transmission frequency. The virus, which
is similar to yet distinct from the two pre-
vious zoonotic coronaviruses from the
21st century, SARS-CoV and MERS-
CoV, marks the third emergence of a co-
ronavirus that is capable of causing se-
vere disease within the last 20 years.
Novel bat coronaviruses have also
emerged in swine populations in the
past few years. As the pace of coronavi-
rus emergence appears to be acceler-
ating, these data not only underscore a
common event in nature but also empha-
size the urgency to develop vaccines and
therapeutics with broad efficacy. Thus,
studies characterizing the SARS-CoV-2
neutralizing epitopes and identifying
broadly cross-neutralizing epitopes are
clear priorities for immunotherapeutic
and vaccine countermeasure design.
This work should be performed with
due caution, ensuring that putative
enhancing epitopes are likewise identi-
fied and avoided in the course of vaccine
design to minimize the risk of potenti-
ating disease. Additionally, T cell epi-
topes should be identified across
outbred populations to determine the
key correlates of protective immunity. A
key priority in combating the current
pandemic and constructing readiness
programs for future emergence events
is the development of broadly effectivemedical countermeasures and therapeu-
tics that can be stockpiled as insurance
against future viral emergence events to
prevent the human loss and economic
and social catastrophe of global
pandemics.
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